Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3

American Journal of Epidemiology

Volumn 174, Issue 6, 2011, Pages 642-651

  Poole, Elizabeth M ^a   Tworoger, Shelley S ^a   Hankinson, Susan E ^a   Schernhammer, Eva S ^a   Pollak, Michael N ^a   Baer, Heather J ^a  

^a NONE

Author keywords

birth weight; body mass index; breast neoplasms; child; growth; insulin like growth factor 1; insulin like growth factor binding protein 3; obesity

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ASSESSMENT METHOD; BODY SIZE; CANCER; CONCENTRATION (COMPOSITION); DEVELOPMENTAL BIOLOGY; GROWTH REGULATOR; HEALTH RISK; HORMONE; OBSERVATIONAL METHOD; PLASMA; PROTEIN;

ADULT; ADULTHOOD; AGED; ARTICLE; BIRTH WEIGHT; BLOOD DONOR; BODY FAT; BODY MASS; BODY SIZE; CHILDHOOD; CONTROLLED STUDY; FEMALE; HUMAN; POSTMENOPAUSE; PREMENOPAUSE;

ADOLESCENT; ADULT; AGED; AGING; BODY SIZE; BREAST NEOPLASMS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES; YOUNG ADULT;

EID: 80052657072     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr123     Document Type: Article

References (62)

1. Michels KB, Xue F. Role of birthweight in the etiology of breast cancer. Int J Cancer. 2006;119(9):2007-2025. (Pubitemid 44423656)
2. Ruder EH, Dorgan JF, Kranz S, et al. Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence. Clin Breast Cancer. 2008;8(4):334-342.
3. Baer HJ, Tworoger SS, Hankinson SE, et al. Body fatness at young ages and risk of breast cancer throughout life. Am J Epidemiol. 2010;171(11):1183-1194.
4. Baer HJ, Hankinson SE, Tworoger SS. Body size in early life and risk of epithelial ovarian cancer: results from the Nurses' Health Studies. Br J Cancer. 2008;99(11):1916-1922.
5. Löf M, Sandin S, Hilakivi-Clarke L, et al. Birth weight in relation to endometrial and breast cancer risks in Swedish women. Br J Cancer. 2007;96(1):134-136. (Pubitemid 46094650)
6. McCormack VA, dos Santos Silva I, Koupil I, et al. Birth characteristics and adult cancer incidence: Swedish cohort of over 11,000 men and women. Int J Cancer. 2005;115(4): 611-617. (Pubitemid 40656720)
7. Park SL, Goodman MT, Zhang ZF, et al. Body size, adult BMI gain and endometrial cancer risk: the Multiethnic Cohort. Int J Cancer. 2010;126(2):490-499.
8. Schouten LJ, Rivera C, Hunter DJ, et al. Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev. 2008;17(4): 902-912. (Pubitemid 351536422)
9. Xu WH, Xiang YB, Zheng W, et al.Weight history and risk of endometrial cancer among Chinese women. Int J Epidemiol. 2006;35(1):159-166. (Pubitemid 43205463)
10. Xue F, Hilakivi-Clarke L, Maxwell G, et al. Longitudinal study on birthweight and the incidence of endometrial cancer. Br J Cancer. 2008;98(7):1288-1291. (Pubitemid 351481686)
11. Campbell PT, Cotterchio M, Dicks E, et al. Excess body weight and colorectal cancer risk in Canada: associations in subgroups of clinically defined familial risk of cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(9):1735-1744. (Pubitemid 47450502)
12. Le Marchand L, Wilkens LR, Mi MP. Obesity in youth and middle age and risk of colorectal cancer in men. Cancer Causes Control. 1992;3(4):349-354.
13. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8(12):915-928.
14. Key TJ, Appleby PN, Reeves GK, et al. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Endogenous Hormones and Breast Cancer Collaborative Group. Lancet Oncol. 2010;11(6):530-542.
15. Wei EK, Ma J, Pollak MN, et al. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2005;14(4): 850-855. (Pubitemid 40478547)
16. Tworoger SS, Lee IM, Buring JE, et al. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts. Cancer Epidemiol Biomarkers Prev. 2007;16(8): 1691-1695. (Pubitemid 47294840)
17. Wolpin BM, Michaud DS, Giovannucci EL, et al. Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer. Cancer Res. 2007;67(16):7923-7928. (Pubitemid 47281389)
18. Major JM, Pollak MN, Snyder K, et al. Insulin-like growth factors and risk of kidney cancer in men. Br J Cancer. 2010; 103(1):132-135.
19. Nimptsch K, Platz EA, Pollak MN, et al. Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993- 2004. Int J Cancer. 2011;128(3):660-667.
20. Fall CH, Pandit AN, Law CM, et al. Size at birth and plasma insulin-like growth factor-1 concentrations. Arch Dis Child. 1995;73(4):287-293.
21. Garnett S, Cowell CT, Bradford D, et al. Effects of gender, body composition and birth size on IGF-I in 7- and 8-year-old children. Horm Res. 1999;52(5):221-229. (Pubitemid 30303714)
22. Ong K, Kratzsch J, Kiess W, et al. Circulating IGF-I levels in childhood are related to both current body composition and early postnatal growth rate. J Clin Endocrinol Metab. 2002; 87(3):1041-1044. (Pubitemid 36121062)
23. Schernhammer ES, Tworoger SS, Eliassen AH, et al. Body shape throughout life and correlations with IGFs and GH. Endocr Relat Cancer. 2007;14(3):721-732. (Pubitemid 350074061)
24. Hankinson SE,Willett WC, Manson JE, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst. 1995;87(17): 1297-1302.
25. Tworoger SS, Sluss P, Hankinson SE. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res. 2006;66(4):2476-2482.
26. Helle SI, Anker GB, Meadows KA, et al. Alterations in the insulin-like growth factor system during the menstrual cycle in normal women. Maturitas. 1998;28(3):259-265. (Pubitemid 28162439)
27. Juul A, Scheike T, Pedersen AT, et al. Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle. Hum Reprod. 1997;12(10):2123-2128. (Pubitemid 27494014)
28. Missmer SA, Spiegelman D, Bertone-Johnson ER, et al. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev. 2006;15(5):972-978. (Pubitemid 43823526)
29. Su X, Colditz GA, Willett WC, et al. Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease. Int J Cancer. 2010;126(1): 180-190.
30. Schernhammer ES, Holly JM, Pollak MN, et al. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005;14(3):699-704. (Pubitemid 40489217)
31. Schernhammer ES, Holly JM, Hunter DJ, et al. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in the Nurses Health Study II. Endocr Relat Cancer. 2006;13(2):583-592. (Pubitemid 43886678)
32. Wei EK, Ma J, Pollak MN, et al. C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women. Cancer Epidemiol Biomarkers Prev. 2006;15(4):750-755.
33. Page JH, Ma J, Pollak M, et al. Plasma insulinlike growth factor 1 and binding-protein 3 and risk of myocardial infarction in women: a prospective study. Clin Chem. 2008;54(10): 1682-1688.
34. Hankinson SE, Willett WC, Michaud DS, et al. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 1999;91(7):629-634. (Pubitemid 29194050)
35. Michels KB, Trichopoulos D, Robins JM, et al. Birthweight as a risk factor for breast cancer. Lancet. 1996;348(9041): 1542-1546.
36. Stunkard AJ, Sorenson T, Schulsinger F. Use of the Danish Adoption Register for the study of obesity and thinness. In: Kety SS, Rowland LP, Sidman RL, et al, eds. The Genetics of Neurological and Psychiatric Disorders. New York, NY: Raven Press; 1983:115-120.
37. Must A, Willett WC, Dietz WH. Remote recall of childhood height, weight, and body build by elderly subjects. Am J Epidemiol. 1993;138(1):56-64. (Pubitemid 23226335)
38. Rosner B. Percentage points for a generalized ESD manyoutlier procedure. Technometrics. 1983;25(2):165-172. (Pubitemid 13540616)
39. Rosner B, Cook N, Portman R, et al. Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol. 2008;167(6):653-666. (Pubitemid 351430930)
40. Ben-Shlomo Y, Holly J, McCarthy A, et al. An investigation of fetal, postnatal and childhood growth with insulin-like growth factor I and binding protein 3 in adulthood. Clin Endocrinol (Oxf ). 2003;59(3):366-373. (Pubitemid 37046991)
41. Holt RI, Syddall HE, Phillips DI, et al. Serum insulin-like growth factor-I concentrations in late middle age: no association with birthweight in three UK cohorts. Acta Physiol Scand. 2004;180(4):359-366. (Pubitemid 38496695)
42. Johnsen SP, Sørensen HT, Thomsen JL, et al. Markers of fetal growth and serum levels of insulin-like growth factor (IGF) I, -II and IGF binding protein 3 in adults. Eur J Epidemiol. 2004;19(1):41-47. (Pubitemid 38250052)
43. Kajantie E, Fall CH, Seppälä M, et al. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth. J Clin Endocrinol Metab. 2003;88(3):1059-1065. (Pubitemid 36337757)
44. Jernström H, Olsson H. Insulin-like growth factor-1 in relation to adult weight and birth weight in healthy nulliparous women. Int J Gynaecol Obstet. 1998;62(1):11-18. (Pubitemid 28342630)
45. Martin RM, Holly JM, Davey Smith G, et al. Associations of adiposity from childhood into adulthood with insulin resistance and the insulin-like growth factor system: 65-year follow-up of the Boyd Orr Cohort. J Clin Endocrinol Metab. 2006;91(9):3287-3295. (Pubitemid 44402093)
46. Fall CH, Clark PM, Hindmarsh PC, et al. Urinary GH and IGF-I excretion in nine year-old children: relation to sex, current size and size at birth. Clin Endocrinol (Oxf ). 2000;53(1):69-76. (Pubitemid 30646128)
47. Holt RI. Fetal programming of the growth hormone-insulinlike growth factor axis. Trends Endocrinol Metab. 2002; 13(9):392-397. (Pubitemid 36723592)
48. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a metaanalysis. Cancer Epidemiol Biomarkers Prev. 2006;15(6): 1159-1169.
49. Brower V. Homing in on mechanisms linking breast density to breast cancer risk. J Natl Cancer Inst. 2010;102(12):843-845.
50. Samimi G, Colditz GA, Baer HJ, et al. Measures of energy balance and mammographic density in the Nurses' Health Study. Breast Cancer Res Treat. 2008;109(1):113-122. (Pubitemid 351538761)
51. Bremnes Y, Ursin G, Bjurstam N, et al. Insulin-like growth factor and mammographic density in postmenopausal Norwegian women. Cancer Epidemiol Biomarkers Prev. 2007; 16(1):57-62. (Pubitemid 46174264)
52. Byrne C, Colditz GA, Willett WC, et al. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res. 2000;60(14):3744-3748. (Pubitemid 32204562)
53. Diorio C, Pollak M, Byrne C, et al. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev. 2005;14(5):1065-1073. (Pubitemid 40656449)
54. Walker K, Fletcher O, Johnson N, et al. Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. Cancer Res. 2009;69(16):6490-6499.
55. Tworoger SS, Eliassen AH, Missmer SA, et al. Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2494-2501. (Pubitemid 46048311)
56. Su X, Hankinson SE, Clevenger CV, et al. Energy balance, early life body size, and plasma prolactin levels in postmenopausal women. Cancer Causes Control. 2009;20(2):253-262.
57. Tworoger SS, Eliassen AH, Sluss P, et al. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol. 2007;25(12): 1482-1488. (Pubitemid 46733075)
58. Hall K, Hilding A, Thorén M. Determinants of circulating insulin-like growth factor-I. J Endocrinol Invest. 1999; 22(suppl 5):48-57.
59. Harrela M, Koistinen H, Kaprio J, et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest. 1996;98(11):2612-2615. (Pubitemid 26415083)
60. Hong Y, Brismar K, Hall K, et al. Associations between insulin-like growth factor-I (IGF-I), IGF-binding protein-1, insulin and other metabolic measures after controlling for genetic influences: results from middle-aged and elderly monozygotic twins. J Endocrinol. 1997;153(2):251-257. (Pubitemid 27219457)
61. Gomez-Merino D, Drogou C, Chennaoui M, et al. Effects of combined stress during intense training on cellular immunity, hormones and respiratory infections. Neuroimmunomodulation. 2005;12(3):164-172. (Pubitemid 40868677)
62. Grunbaum-Novak N, Taler M, Gil-Ad I, et al. Relationship between antidepressants and IGF-1 system in the brain: possible role in cognition. Eur Neuropsychopharmacol. 2008; 18(6):431-438. (Pubitemid 351608552)